Zennova Pharma Wins Major Award at the 7th Shenzhen International Innovation & Entrepreneurship Competition

May 08, 2024 15:47 CST Updated 15:47

Zennova

Specialty Drug Research and Development, Manufacturer

Haoyue Values

MissionEmpower with Capital, Achieve Excellence in Healthcare Enterprises

VisionTo become the most outstanding investment bank in China's healthcare industry

HaoYue Capital, founded in January 2014, is a leading investment bank in China focusing on the healthcare industry. Headquartered in Shanghai, the company has regional offices in Beijing, Shenzhen, and Hong Kong. HaoYue Capital is committed to leveraging capital and research-driven insights to help outstanding enterprises in China's healthcare sector successfully access the capital markets and create added value for clients. The partnership team at HaoYue Capital consists of senior investment bankers with years of deep engagement in China’s healthcare industry. HaoYue Capital continuously tracks market dynamics and investment trends in healthcare, covering areas such as innovative pharmaceuticals, advanced medical devices, IVD and life sciences, health services, and smart healthcare across various sub-sectors. As of 2023, HaoYue Capital has completed nearly 400 projects with a total transaction value exceeding tens of billions of US dollars, including over 50 mergers and acquisitions deals totaling more than 50 billion US dollars. In 2023 alone, HaoYue Capital executed nearly 50 private equity financings, mergers, integrations, and spin-offs of listed companies involving complex transactions worth billions of US dollars, maintaining a comprehensive leadership position across all sub-sectors of the healthcare industry.

The 7th Shenzhen Innovation Competition International Race: Zennova Stands Out,

Winning Heavyweight Awards

On April 18, the 7th China Shenzhen Innovation and Entrepreneurship Competition International Edition was grandly held in Longgang District, Shenzhen. Since October 2023, it has been awarded "Silicon Valley, USA, Full IndustrySub-station CompetitionAfter winning the "First Prize" (1st place), Zennova Pharmaceuticals Group further excelled in this competition, standing out against 180 overseas winning projects from 30 countries and regions. It achieved an excellent result by winning the "Third Prize in the Biomedical and Health Industry Final" (5th place).

Zennova is a multinational pharmaceutical enterprise with a complete industrial chain, possessing proprietary drug R&D technology and an international formulation production and R&D center that meets international quality standards for all dosage forms. It has established an international pharmaceutical market sales network covering over 25 countries and regions worldwide. In addition to self-developed products, it provides various services for overseas drug development, including R&D, registration, production, and global market sales cooperation. The company has already initiated comprehensive cooperation with multiple international pharmaceutical enterprises, and currently, Zennova has received FDA approval for over 65 varieties and 200 specifications of drugs entering its sales channels in China and internationally. The full-dosage international formulation center located in Chengdu, China, is expected to pass U.S. FDA certification in the second half of this year, with products to be exported to the United States and global international markets.

In the U.S. division of Shenzhen's entrepreneurship competition, Zennova stood out by"Zennova Pharmaceuticals Group – Building an Innovative Multinational Pharmaceutical Enterprise with R&D in China and the US, Production in China, and Global Marketing"The participating project won the first place in the entire industry.

Figure 1: Mr. Guo Dahai, Founder, Chairman and CEO of Zennova, in the competition

Figure 2 Zennova Pharmaceuticals Group Wins First Prize in the U.S. Silicon Valley Industry-wide Sub-competition

In April 2024, Zennova was invited to participate in the 7th International Competition of China Shenzhen Innovation and Entrepreneurship Competition, Biomedical and Health Industry Final. General Manager of Greater China Region, Zennova Pharmaceuticals GroupMr. Li YaliOnce again outperformed competitors in overseas contests, securing 5th place and winning the industry's third prize. As one of the few Chinese pharmaceutical projects to enter the finals, Zennova Pharmaceuticals Group received unanimous praise for its original technical advantages, outstanding product highlights, and innovative business model. Zennova possesses the world's advanced drug development innovation technology platform, BioCarrier.^TM, this technology platform was originally developed by Zennova, leading globally, capable of carrying drug molecules acrossBlood-Brain Barrier, while comprehensively eliminating drug interference, significantly enhancing biosafety, and improving the solubility of insoluble drug moleculesBioavailability。

Figure 3 Group photo of industry finals participants

Figure 4 Award Ceremony for Industry Final Winners

Looking ahead to the future, with the support of its own R&D technical capabilities, platform innovation capabilities, and abundant industry resources, Zennova will surely supply more and more good products, new products, and valuable products globally. While ensuring rapid market entry in China and multiple overseas national-level regions, and bringing sustainable operating capacity to the company, it will also create more value for shareholders and society.

China (Shenzhen) Innovation and Entrepreneurship Competition International Tournament is an international innovation and entrepreneurship brand event hosted by the Shenzhen Municipal Government and jointly organized by the Shenzhen Human Resources and Social Security Bureau and relevant district governments. It is the largest and most well-known innovation and entrepreneurship competition held by China overseas. Since its establishment in 2016, it has attracted more than 10,000 outstanding projects from around the world. The 7th tournament set up overseas division competitions in 14 cities including Silicon Valley in the United States, Munich in Germany, Tokyo in Japan, and Sydney in Australia, becoming a global event covering major international innovation regions in North America, Europe, Asia, and Oceania. The event gained widespread attention overseas, with counselors from Chinese embassies and consulates abroad, local government officials, and distinguished guests attending the overseas division competitions.

About Zennova

Zennova Pharma Group is an innovative international pharmaceutical company group with three strategic focuses: Made in China, global research and development, and global market. It concentrates on four therapeutic areas: ophthalmology, viruses, cardiovascular, and oncology. Zennova Pharma Group currently has R&D bases in New York and New Jersey, USA, a contract manufacturing plant in Chicago, USA, and an all dosage forms international preparation center that integrates R&D, production, and sales in Chengdu, China. The company possesses Liquipuls, a globally original technology researched and developed over 20 years in the United States.^®+Biocarrier^TMNew Drug Development Technology Platform. Zennova Pharmaceuticals Group always adheres to the core value of "Commitment to Life, Scaling Pharmaceutical Peaks" (Innovation for better medicine), achieving high-level production and high-quality export of medicines, promoting the internationalization of Chinese pharmaceuticals, and developing effective and innovative drugs for the cause of human health.

Contact Us

Shanghai Office

Room 2302, Qiantan Center, No. 555 Haiyang West Road, Pudong New Area

Rm 2302, New Bund Center, 555 West Haiyang Rd, Pudong New Area, Shanghai

北京办公室 Beijing Office

Room 3608, Taikang Financial Tower, Building 1, Yard 38, North Third Ring Road, Chaoyang District, Beijing, China

3608, Taikang Financial Building, Building 1, Yard 38, North Rd of East 3rd Ring, Chaoyang District

Shenzhen Office

Room 25J, Building A, NEO Tower, No. 6011 Shennan Avenue, Futian District

J, 25F, Tower A, NEO Building, 6011 Shennan Avenue, Futian District, Shenzhen

Hong Kong Office

10th Floor, Manulife Plaza, 33 Lockhart Road, Wan Chai District

10th Floor, YF Life Tower, 33 Lockhart Road, Wan Chai, Hong Kong

Project Delivery

info@healthcarecapital.com.cn

媒体问询 Media inquiries

pr@healthcarecapital.com.cn

Recruitment

hr@healthcarecapital.com.cn